Locanabio

Locanabio
https://locanabio.com

Field:
Genetic Engineering

Focus:
Body

Type: Startup
Founded: 2016
HQ: United States

Leadership
David Nelles
Founder
[LinkedIn]

Gene Yeo
Founder
[LinkedIn]
[Twitter]

Richard Schneeberger
Founder (not involved anymore)
[LinkedIn]

Funding


Raised Capital
Year
Type
Offered / Sold Amount
Filings
Reported by Press*
Round
2019
55M USD
Series A
2020
100M USD
Series B
Known Investors
Name
Type
HQ
Other Relevant Investments
Acuta Capital
Venture Capital
United States
ARCH Venture Partners
Venture Capital
United States
Elysium Health
Aira
Prime Medicine
Beam Therapeutics
GV
Corporate Venture
United States
CTRL-labs
Prime Medicine
Beam Therapeutics
Editas Medicine
Invus Group
Private Equity
United States
JLabs
Accelerator
United States
Volumetric
Lightstone Ventures
Venture Capital
United States
SetPoint Medical
SVB Leerink
Investment Bank
United States
Temasek Holdings
Corporation
Singapore
ŌURA
Verily
Magic Leap
UCB Ventures
Corporation
Belgium
Vida Ventures
Venture Capital
United States
*More data available at: [CB Insights] [CrunchBase] [PitchBook]
Related
News
Locana uses CRISPR to target RNA, not DNA, and address Huntington’s disease, ALS and myotonic dystrophy